Skip to content

Observation on spasmolytic effect of Danshu capsule in non-anesthetic colonoscopy

Observation on spasmolytic effect of Danshu capsule in non-anesthetic colonoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110527
Enrollment
Unknown
Registered
2025-10-15
Start date
2024-06-06
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-anesthetic colonoscopy

Interventions

Danshu capsule group:Oral administration of Danshu capsule 1 hour before non-anesthetic colonoscopy
Anisodamine group:Anisodamine was intramuscularly injected 10 minutes before non-anesthetic colonoscopy

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 80 years old ; 2.with colonoscopy screening, monitoring and diagnostic indications ; 3.no previous history of colorectal cancer or colorectal surgery ; 4.no previous history of inflammatory bowel disease or familial intestinal polyps ; 5.written informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1.Aged 80 years ; 2.previous history of colorectal cancer or colorectal surgery ; 3.have a history of inflammatory bowel disease or familial intestinal polyps ; 4.suspected colorectal cancer ; emergency colonoscopy or therapeutic colonoscopy ; 5.intestinal obstruction ; pregnancy or lactating women ; coagulation dysfunction ; 6.patients allergic to Danshu capsule or anisodamine ; 7.have a history of taking aspirin, clopidogrel or other anticoagulant and antiplatelet drugs within 7 days ; 8.combined with severe heart, lung, liver, kidney and brain diseases can not tolerate colonoscopy ; 9.refuse to participate or refuse to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Antispasmodic efficiency;

Secondary

MeasureTime frame
Colonic peristalsis classification;Pain score;Degree of discomfort classification;Adenoma detection rate;

Countries

China

Contacts

Public ContactZhang Lu

Lishui Central Hospital

447430014@qq.com+86 139 5704 7387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026